Vandetanib Plus Pemetrexed Versus Pemetrexed as Second-Line Therapy in Patients with Advanced Non-Small Cell Lung Cancer (Nsclc): A Randomized, Double-Blind Phase Iii Trial (Zeal)
Resource
JOURNAL OF CLINICAL ONCOLOGY v.27 n.15 SUPPL. S pp.8010
Journal
JOURNAL OF CLINICAL ONCOLOGY
Journal Volume
v.27
Journal Issue
n.15
Pages
801-0
Date Issued
2009
Date
2009
Author(s)
YANG, CHIH-HSIN
SDGs